Apuli Maricel (CIK 2058197) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-18). Recent activity: Sell BBIO (4,714 shares), Sell BBIO (2,000 shares), Sell BBIO (4,714 shares), Sell BBIO (2,000 shares), Buy BBIO (14,170 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 4,714 | $376,460 |
| 2026-08-03 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 2,000 | $160,120 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 4,714 | $311,737 |
| 2026-05-04 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 2,000 | $143,160 |
| 2026-03-20 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Buy | 14,170 | $0 |
| 2026-02-27 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 2,000 | $132,000 |
| 2026-02-18 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 4,349 | $327,262 |
| 2026-02-18 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 510 | $37,898 |
| 2025-12-16 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 2,003 | $150,525 |
| 2025-12-10 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 2,000 | $148,520 |
| 2025-11-18 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 4,781 | $317,411 |
| 2025-08-19 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 4,781 | $245,361 |
| 2025-08-11 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 1,000 | $45,440 |
| 2025-05-20 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 4,780 | $161,755 |
| 2025-05-06 | BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | Sell | 1,026 | $39,511 |
来源：SEC Form 4 申报文件 · 截至 2026-08-18